Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Vaccine shows promise in preventing mono

Vaccine shows promise in preventing mono

December 11, 2007

A new study suggests that a vaccine targeting Epstein-Barr virus (EBV) may prevent infectious mononucleosis, commonly known as "mono" or "glandular fever." The study is published in the December 15 issue of The Journal of Infectious Diseases, now available online.

EBV is a member of the herpes virus family and one of the most common viruses in humans, with nearly all adults in developed countries such as the United States having been infected. EBV is often asymptomatic but commonly causes infectious mononucleosis, with 30 to 40 percent of adolescents who contract the virus developing the disease. EBV is also associated with a number of other diseases, some of the most serious being lymphomas and other lymphoproliferative diseases in people with compromised immune systems, such as transplant patients. Despite the frequency of EBV infections and infectious mononucleosis, the new study is the first to suggest the efficacy of a vaccine in preventing infectious mononucleosis.




The study was conducted by Etienne M. Sokal, MD, PhD, and colleagues at several Belgian institutions and pharmaceutical companies. The vaccine targets glycoprotein 350, a protein that facilitates the entry of EBV into immune system cells. In this preliminary, Phase II clinical trial, 181 young adults who had not previously been infected by EBV received three doses of either a placebo or the vaccine.

During the 18-month observation period, the proportion of symptomatic EBV infections was reduced from 10 percent (nine out of 91) in the control group to 2 percent (two out of 90) in the vaccinated group, indicating that those who did not receive the vaccine were almost 5 times more likely to develop infectious mononucleosis.

With these promising results in a small group of subjects, Dr. Sokal suggested the next step should be "large-scale studies on the benefit in healthy subjects and ability to prevent acute EBV infection and post-transplant lymphoproliferative diseases in transplant patients." He added, "There is currently no possibility to prevent or to treat acute mononucleosis, which has remained so far an unmet medical problem. This vaccine may decrease the socio-economic impact of acute mononucleosis."

Development of an EBV vaccine has had a slow and problematic history. These results suggest that the prevention of infectious mononucleosis is possible, and provide a framework for future trials looking to prevent more serious consequences of EBV infection.

In an accompanying editorial, Henry H. Balfour, Jr., MD, of the University of Minnesota Medical School, noted the importance of such studies on EBV vaccines, especially because "the worldwide disease burden due to EBV is enormous." Balfour agreed that these findings should stimulate future research and larger clinical trials on the prevention and treatment of diseases associated with EBV.

Infectious Diseases Society of America



Related Mononucleosis Current Events and Mononucleosis News Articles Mononucleosis Current Events and Mononucleosis News RSS Mononucleosis Current Events and Mononucleosis News RSS
OHSU finds association between Epstein-Barr virus, inflammatory diseases of the mouth
Researchers at Oregon Health & Science University's School of Dentistry (www.ohsu.edu/sod) have found that a significant percentage of dental patients with the inflammatory diseases irreversible pulpitis and apical periodontitis also have the Epstein-Barr virus.

OHSU research suggests America may over-vaccinate
A new study published in the New England Journal of Medicine this week by Oregon Health & Science University researchers suggests that timelines for vaccinating and revaccinating Americans against disease should possibly be reevaluated and adjusted.

Epstein-Barr: a virtual look at a vexing virus
Researchers at Tufts University School of Medicine in collaboration with the Virginia Bioinformatics Institute at Virginia Tech have created a computer program called Pathogen Simulation (PathSim) to study the progression of Epstein-Barr virus (EBV) in humans.

An AIDS-related virus reveals more ways to cause cancer, Penn researchers find
Researchers at the University of Pennsylvania School of Medicine have shed new light on how Kaposi's Sarcoma-associated Herpes Virus (KSHV) subverts normal cell machinery to cause cancer.

Common blood test can help distinguish between mononucleosis and tonsillitis
Measuring a patient's ratio of white blood cell types may help physicians accurately distinguish between the similar conditions infectious mononucleosis and bacterial tonsillitis, potentially guiding treatment decisions.

New lab mice pave way for novel studies of human infection
A new type of laboratory mouse developed at UT Southwestern Medical Center can fight certain infections the same way humans do, making the rodents very useful for novel studies of human-pathogen interaction and developing disease therapies.

Clue found to Epstein-Barr virus' ability to form and sustain tumors
Researchers at the University of Wisconsin School of Medicine and Public Health (SMPH) have found a viral target that opens the door for the development of drugs to destroy tumors caused by Epstein-Barr virus (EBV).

Innovative method for creating a human cytomegalovirus vaccine outlined
Each year, about 40,000 children are born infected with human cytomegalovirus, or CMV, and about 8,000 of these children suffer permanent disabilities due to the virus - almost one an hour.

Mice lacking key immune component still control chronic viral infections
Despite lack of a key component of the immune system, a line of genetically engineered mice can control chronic herpes virus infections, researchers at Washington University School of Medicine in St. Louis have found.

Epstein-Barr Virus Might Kick-Start Multiple Sclerosis
Researchers have found that patients with multiple sclerosis (MS) carry a population of immune cells that overreact to Epstein-Barr virus.
More Mononucleosis Current Events and Mononucleosis News Articles


21st Century Complete Medical Guide to Infectious Mononucleosis and the Epstein-Barr Virus (EBV), Authoritative Government Documents, Clinical References, ... for Patients and Physicians (CD-ROM)
by PM Medical Health News

This up-to-date electronic book on CD-ROM provides the best collection available anywhere of official Federal government information and documents on the subject of Infectious Mononucleosis and the Epstein-Barr Virus (EBV). This CD-ROM uses next-generation search technology that allows complete indexing and makes all files on the disc fully searchable. For patients, practical information is...



Infectious Mononucleosis (Diseases and Disorders)
by Hal Marcovitz



Mononucleosis (Health Alert (Benchmark Books).)
by Gretchen Hoffmann

Everything You Need to Know About Mononucleosis (Need to Know Library)
by P. Smart

Discusses the nature and diagnosis of mononucleosis and how to protect against it or cope with having...

Gale Encyclopedia of Nursing and Allied Health: Infectious mononucleosis test
by Victoria E. DeMoranville

The article is excerpted from Gale Encyclopedia of Nursing and Allied Health. This 5-vol. set provides more than 850 entries covering topics in nursing and allied health written for students and professionals in the field. Alphabetically arranged entries cover topics in body systems and functions, conditions and common diseases, issues and theories, techniques and practices, and devices and...

Infectious Mononucleosis (Modern Medical Monographs)
by Sidney Leibowitz

Mononucleosis means delaying contact sports. (1-3 Months After Symptom Onset).: An article from: Pediatric News
by Betsy Bates

This digital document is an article from Pediatric News, published by International Medical News Group on October 1, 2002. The length of the article is 451 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation...

How to handle suspected mono in athletes. (Keep Kids Benched if Energy is Low).(mononucleosis treatment): An article from: Pediatric News
by Heidi Splete

This digital document is an article from Pediatric News, published by International Medical News Group on May 1, 2003. The length of the article is 660 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation...

Understanding the Enigma That Is Mononucleosis.(Brief Article): An article from: Pediatric News
by Christopher J. Harrison

This digital document is an article from Pediatric News, published by International Medical News Group on September 1, 2001. The length of the article is 775 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation...

Mononucleosis and Other Infectious Diseases
by Laurel Shader & Jon Zonderman

© 2008 BrightSurf.com